Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
Antoîne Italiano, Alban Bessede, M. Pulido, Emmanuelle Bompas, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, François Bertucci, Maud Toulmonde, Carine Bellera, Jean‐Philippe Guégan, Christophe Rey, Catherine Sautès‐Fridman, Antoine Bougoüin, Coralie Cantarel, Michèle Kind, M. Spalato, Bérengère Dadone‐Montaudié, François Le Loarer, Jean‐Yves Blay, Wolf H. Fridman
Topics & Concepts
PembrolizumabMedicineInternal medicineClinical endpointOncologySoft tissue sarcomaNauseaCohortRetrospective cohort studyProgression-free survivalSurrogate endpointConfidence intervalCyclophosphamideAdverse effectSurgeryClinical trialSoft tissueCancerChemotherapyImmunotherapySarcoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment